Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.7MFederal grants as PI9 awards
1Patents grantedLatest Oct 8, 2019
77Papers2,833 citations
Federal awards and patents by year
AwardsPatents
9 awards · $3.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 15, 2021 | NIH | SBIR Phase II Targeting multiple signaling pathways for tinnitus prevention and treatment | $1.2M | GATEWAY BIOTECHNOLOGY, INC. |
| Jun 18, 2020 | NIH | SBIR Phase II Targeting multiple signaling pathways for tinnitus prevention and treatment | $973K | GATEWAY BIOTECHNOLOGY, INC. |
| Sep 4, 2019 | NIH | STTR Phase I An unique patient population for clinical trials against noise-induced hearing loss | $100K | GATEWAY BIOTECHNOLOGY, INC. |
| Nov 19, 2018 | NIH | STTR Phase I Developing a Nutraceutical Product against Ototoxicity | $205K | GATEWAY BIOTECHNOLOGY, INC. |
| Sep 1, 2018 | NIH | STTR Phase I An unique patient population for clinical trials against noise-induced hearing loss | $325K | GATEWAY BIOTECHNOLOGY, INC. with WASHINGTON UNIVERSITY |
| Sep 21, 2017 | NIH | STTR Phase I Developing a Nutraceutical Product against Noise Induce Hearing Loss | $225K | GATEWAY BIOTECHNOLOGY, INC. with CALSPAN-UNIVERSITY OF BUFFALO RES CENTER |
| Sep 18, 2017 | NIH | STTR Phase I Developing a Nutraceutical Product against Noise-Induce Hearing Loss | $225K | GATEWAY BIOTECHNOLOGY, INC. |
| Jul 5, 2017 | NIH | STTR Phase I Develop a new cisplatin-based drug combination with reduced ototoxicity | $225K | GATEWAY BIOTECHNOLOGY, INC. |
| May 1, 2016 | NIH | STTR Phase I Preclinical Testing of Tetrandrine against Noise-Induce Hearing Loss | $225K | GATEWAY BIOTECHNOLOGY, INC. |
2 patents as inventor
- US 10434097GATEWAY BIOTECHNOLOGY, INC.Oct 8, 2019
- US GATEWAY BIOTECHNOLOGY, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#476
Awards as PI#166
Patents#284
Companies
- GATEWAY BIOTECHNOLOGY, INC.Leads (SEC Form D) · Medtech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.